Protein crystal growth in low gravity by Feigelson, Robert S.
^£
Jun. -
J9883) PP.OTtIN C R Y S T A L
•miannual Technical
;c. 1991 (Stanford i
CSCL
CENTER FOR MATERIALS RESEARCH
STANFORD UNIVERSITY • STANFORD, CALIFORNIA
https://ntrs.nasa.gov/search.jsp?R=19920009005 2020-03-17T12:35:17+00:00Z
The Board of Trustees of the
Leland Stanford Junior University
Center for Materials Research
Stanford, California 94305-4045
Santa Clara, 12th Congressional District
Semi-Annual Technical Report
on
PROTEIN CRYSTAL GROWTH IN LOW GRAVITY
NASA #NAG8-774
CMR-92-1
SPO#7218
for the period
June 6,1991 through December 6, 1991
Submitted to
George C. Marshall Space Flight Center
ES-76, Space Science Lab
MSFC, AL 35812
Principal Investigator:
Robert S. Feig€lson,
Center for Materials Rese
Stanford, California 9430
(415) 723-4007
February 1992
TABLE OF CONTENTS
ABSTRACT
I. INTRODUCTION
II. ISOCTTRATELYASE
III. CONTROL OF NUCLEATION
IV. REFERENCES 13
V. FIGURES 14
ABSTRACT
This report covers the period of June 6,1991 to December 6,1991 for NASA Grant
NAG 8-774. The objectives of and approach to the research is outlined. A study of the
crystallization of isocitrate lyase (ICL) is presented and the influence of the lack of thermal-
solutal convection in p.g on the morphology of ICL crystals is discussed. The latest results
of studies with thermonucleation are presented. These include the nucleation of a protein
with retrograde solubility and an unknown solubility curve. A new design for a more (ig
compatable thermonucleator is presented.
I. INTRODUCTION
The objective of this research is to study the effect of low gravity on the growth of
protein crystals and those parameters which will affect growth and crystal quality. The
proper design of the flight hardware and experimental protocols are highly dependent on
understanding the factors which influence the nucleation and growth of crystals of
biological macromolecules. Thus, the primary objective of this research is centered on
investigating those factors and relating them to the body of knowledge which has been built
up for "small molecule" crystallization. This data also provides a basis of comparison for
the results obtained from low-g experiments.
The main component of this research program is the study of mechanisms involved
in protein crystallization and those parameters which influence the growth process and
crystalline perfection. Both canavalin and lysozyme are being used as the basic model
proteins in these studies. Other biological macromolecules such as isocitrate lyase have
been included in this research program when they provide an opportunity to better
understand the nature of the crystallization process. The program involves four broad
areas:
1. The application of both classical and novel chemical and physical techniques to
study the fundamentals of protein crystallization. Included in this area are the study
of the phase relationships in the systems of interest, primarily the factors
controlling solubility, the study of growth kinetics to determine the growth rate
controlling mechanism and the relevant activation energy involved in the process.
The effects of fluid flow on the growth and perfection of protein crystals will be
studied using flow visualization techniques. The use of electrochemical techniques
to monitor and/or control crystallization will be studied also. The effects of applied
voltages on nucleation and growth are not known nor is the magnitude of the
potentials which may develop on the crystal during growth.
2. Characterization of protein crystals. Optical microscopy will give a general
evaluation of crystal morphology, size and perfection. Phase contrast techniques
will give enhanced contrast to the surface features allowing observation down to the
0.1(1 level. For more detailed surface imaging the application of Scanning
Tunneling Microscopy and Atomic Force Microscopy to protein crystals will be
investigated. To study the defects occurring in the bulk of the crystals, the
applicability of Synchrotron x-ray topography will be studied. The characterization
studies will be attempting to associate the defects in protein crystals with the growth
conditions to develop insights for growing crystals of greater perfection.
3. Control of nucleation and growth. The information developed in the phase
relationship studies of section (1) will be used to design experiments to separately
control the nucleation and growth processes. The information from section (2) will
be used to optimize the growth.
4. The design and construction of a prototype of space flight hardware. The design
will incorporate the results of section (3) and will be instrumented to gather the
types of data that have been acquired in the ground based studies.
II. ISOCITRATE LYASE
The structure of the protein isocitrate lyase (ICL) has been under study for a
number of years at Du Pont Merck. Attempts to grow isocitrate lyase crystals by the
hanging drop method produced crystals with very poor growth morphologies (Fig. 1). It
was not immediately clear whether this poor morphology was due to unstable growth
conditions or sedimentation. A series of experiments were designed to answer this
question. In addition to the ground based experiments, ICL has been flown as part of the
NASA shuttle program. As a result of these experiments and the application of theoretical
evaporation models to the crystallizing system, factors affecting the growth of ICL crystals
and, by extension, other protein crystals became apparent.
All of the ICL used in these experiments came from Du Pont Merck. Before use,
the ICL solution (ICL in 0.1M Tris-HCl pH 7.8, lOmM EDTA, ImM DTT, 0.4M KC1)
was incubated at 4°C for 24 hrs with a reducing solution (0.3M Glutathione, 66mM EDTA
in 1M Tris-HCl pH 8.0) (4:100 v/v) and an inhibitor solution (50mM 3-nitriproprionate,
0.5M MgOAc in 50mM Tris-HCl pH 7.0) (4:100 v/v). The ICL concentrations were
lOmg/ml (Du Pont Merck) and 12mg/ml (Stanford). The well solution was 1.6-2.0M (60-
80% saturation) Na-citrate (Na-cit). The usual drop size was 4|il (2(il ICL solution and 2|il
well solution). Crystals appeared within one week at 24°C.
The source of the poor morphology was investigated by closely observing drops
during crystallization. These 4^1 hanging drops (12mg/ml ICL solution, 72% Na-Cit well
solution) were observed through a microscope at 150x.
Figure 2 shows a typical result of the 4p.l hanging drop experiments. The crystal is
more obviously dendritic than those grown from a 30(il drop (Fig. 1). It is obvious that
the poor morphology resulted from uncontrolled growth originating at the corners of the
crystal. Such growth can result from either excessive supersaturationf1] or from flow
effects. P] In an attempt to separate these effects, a glass schlieren imaging cell (1mm x
3mm rectangular cross section) was built and 4[il of ICL crystallizing solution was vapor
equilibrated against Na-cit in the well of the cell. While no flows were observed, in this
experiment, the three crystals were found growing in this cell had a more regular
morphology than had been previously observed in the hanging drop experiments (Fig. 3).
The same growth experiment was repeated in circular cross section capillaries
(1.88mm diameter) to better observe the crystals. The ICL crystals grown in these
capillaries exhibited a very well formed morphology (Fig. 4). These crystals have been x-
rayed and have the same space group (P2i2i2i) and unit cell parameters (a=80.7A,
b=123.lA, c=183.4A) as the previously grown crystals. The "octagonal" cross section
arises from the orthorhombic symmetry with the facets bounded by (100), (010) and (110)
faces. The end of the crystals are bounded by either (001) (flat) or (101) (wedge shaped)
faces.
A comparison of Figs. 2 & 4 shows that the initial breakdown in morphology
occurs at the corners of the crystal. This breakdown is probably associated with excessive
supersaturation and, thus, with unstable growth conditions.
Sibille and his co-workers have developed mathematical models to describe the
evaporation from both drops and capillaries in equilibrium with well solutions. f3»4^ These
models may be expressed in the general form as:
a) for the hanging drop
t/t = F[x(t)]
and b) for the capillary
t/t = G[3(t)]
where
x(t) = ^ -;V(t) = Hv(<x) a(t)3; Qv(a) = i n cos4^ a)[ 1+2 sin2^- a)]
where a is the contact angle of the drop, and
3(t) = ^ -; Ai(t) = ni(e)[t] - ni(c)[t]
Ai(0)
where n i (e)[t] is the number of moles of water in the crystallizing solution and n i (c)[t] the
number of moles of water in the well. The characteristic times, t, for the two models are
defined by:
a) for the hanging drop
T= ; Qa(oc) = 4 K cos2 (^- a)
and b) for the capillary
T^RTLA! 2(0)
4S DI p*i W Tl2
where ni(b) is the number of moles of water in the well, DI the diffusion coefficient of
water in air, piO the vapor pressure of pure water, w the vapor pressure lowering constant,
n2(b) the number of moles of precipitant in the well, Vj the partial molar volume of water,
L the distance between the crystallizing solution and the well, S the cross sectional area of
the capillary, n2 the total number of moles of precipitant in the crystallizing solution and the
well, and R and T have their usual meaning. The parameters needed to use these models
for ICL and lysozyme were calculated as outlined in ref.Bl The osmotic coefficient for Na-
cit was estimated using equation 10, section 14 of Shoemaker and Garland.^ The contact
angle for the hanging drop simulations was 90°, the well volume 500^1 and the spacing
5mm. The well volume for the capillary simulations was 350fil and the spacing was
3.5cm. Figure 5 compares the results of applying these models to a drop and a 1.88mm ID
capillary containing the same volume of ICL solution. The drop evaporates at a rate which
is two orders of magnitude faster than the capillary. This difference in rates is consistent
with laboratory observations.
The rate of change of supersaturation is somewhat more complicated than the rate of
change in volume of the crystallizing solution since the concentration of both the
crystallizing species and the precipitant change with the change in volume and, through the
solubility curve, both affect the supersaturation. The supersaturation is further affected by
the growth of crystals in the solution. Unfortunately, neither the solubility curve nor the
growth kinetics of ICL is known. In order to estimate how supersaturation would change
during crystal growth by vapor equilibration, the models of Sibille et al ^^ were applied
to lysozyme crystallization using the solubility data reported by Puseyf6! and the growth
kinetics described by Pusey and NaumannJ7! The growth solution modelled contained
30mg/ml lysozyme and 2% NaCl equilibrated against a well of 4% NaCl. Ten crystals were
assumed to nucleate at c/s = 4 (a value consistent with other studies). No further nucleation
was allowed to take place. The amount of lysozyme removed from solution during each
growth period was determined. Figure 6 shows the results for both a hanging drop and a
capillary. The supersaturation in the drop reaches a peak which is almost double that of the
capillary. The crystallizing system can react to this increased supersaturation by either 1)
nucleating more crystals (secondary nucleation), 2) increasing the growth rate to the point
of instability or 3) a combination of the two. Lysozyme does the latter exhibiting
secondary nucleation together with surface roughening. ICL ,on the other hand, exhibits
morphological instability
Figure 7 shows an ICL crystal which was grown by Du Pont Merck in low-g
during a shuttle mission. The morphology is greatly improved over those grown by the
hanging drop technique on Earth. The drops used in space were larger (30^1 vs. 4^1) than
those used on Earth which raises the question of whether the improvements in crystal
quality are related to the effects of (j.g or simply the difference in evaporation rate. Figure 8
shows the theoretical evaporation rates for 4|il and 30|il drops. The rate of equilibration
was 5x slower for the larger drop, but the crystals shown in Figs. 1 & 2 were grown under
the same conditions. While there was some improvement in the morphology of the 1-g
crystal grown from a 30|il drop (Fig. 1), the decrease in equilibration rate can not
satisfactorily explain the greatly improved morphology found in the ICL crystals grown in
space from the same size drop.
There are other factors which may affect the morphology of space grown crystals.
It has been pointed^ out that drops evaporate slower than predicted in space due to the
existence of a concentrated layer of precipitant near their surfaces which lowers the vapor
pressure of the drop and retards evaporation. The preliminary data in ref.t3! indicated that
the rate of evaporation decreased by a factor of about 2. This would produce a lower
evaporation rate (lOx) for 30(il drops in jig compared to 4|il drops at 1-g. This is still an
order of magnitude faster than the equilibration rates for the capillary experiments. Clearly,
the reduced equilibration rate due to the presence of a concentrated salt layer at the liquid-
vapor interface was not the only factor contributing to the improved quality of the space
grown ICL crystals.
In an attempt to simulate |ig conditions on the ground and to provide a further basis
for comparison between protein crystal growth at 1-g and fig, a series of capillary ICL
crystal growth experiments were preformed together with some simulated growth
experiments (identical solutions without protein). Experiments were conducted with the
capillary in both the normal and inverted positions. In the latter case, it was hoped that
gravity would stabilize the denser salt layer at the liquid-vapor interface. In the simulated
growth experiments, the inverted capillaries equilibrated at a slightly slower rate. In the
actual growth experiments, a precipitate layer appeared at the liquid-vapor interface in the
inverted capillaries. No precipitate was found in the normal capillaries, nor did such layers
appear in the simulated growth experiments and it must be concluded that the precipitate
was isocitrate lyase. In some cases crystals eventually grew in this layer. The existence
of the precipitate in the surface layer decreases the supersaturation in the ICL solution in the
same manner as the growing crystals did in the lysozyme growth simulation. Therefore,
the ICL crystals were actually growing from a lower supersaturation than would be
expected on the basis of evaporation alone. If Sibille's model of the stable surface layer in
Jj.g[3] is correct, then this mechanism can explain the improved crystal morphology seen in
the ICL |ig experiments.
"Octagonal" ICL crystals were only observed in the normal capillary configuration.
This configuration promotes solutal convection. The solute Rayleigh number based on a
ICL crystallizing solution with a depth of 7.2mm is approximately 2xl06 which is in
excess of the critical Rayleigh number for aqueous solutions of 300. Even correcting for
the size of the capillary, the Rayleigh number would be as high as 104. The time for onset
of convection calculated from the time dependent Rayleigh number was approximately
IxlO'3 seconds. There will be mixing in this configuration and the results indicate that
some degree of mixing is desirable in the growth of ICL from capillaries.
The poor morphology of the ICL crystals grown by the hanging drop method in 1-g
was due to high (unstable) growth rates due to high supersaturation. While it is necessary
in all unseeded "batch" type crystal growth to increase the supersaturation high enough to
cause nucleation, a slower rate of increase of the supersaturation does lead to more
controlled growth and crystals with better morphology. This effect is further mitigated by
the presence of growing crystals or a precipitate both of which will act to lower the overall
supersaturation. The slow rate of supersaturation can be achieved by using vapor diffusion
equilibration in small diameter capillaries. An alternative approach which is potentially
more controllable is to use the method proposed by Wilson and co-workers^ in which
flowing nitrogen of controlled humidity controls the rate of evaporation.
The ICL growth experiments conducted in the capillaries indicate that some
convective mixing is beneficial to the crystal growth by providing mixing and a uniform
supersaturation in the crystallizing solution. Pusey and co-workers^ have demonstrated
in the case of lysozyme that high flow rates can cause cessation of growth. However, most
small molecule aqueous crystal growth is done with some form of stirring (see i.e.
Buckley^10] and Chernov^). The best crystals will be expected to be found between the
extremes of no flow (mixing) and rapid flows which can cause cessation of growth in
protein systems.
The usual flows found in protein crystallization are due to solutal convection where
gravity acts on density differences at the growth interface or at the vapor-liquid interface
where evaporation is taking place. These flows can be non-uniform and unpredictable.
The capillary experiments with ICL may have been fortuitous in that the size of the capillary
and the volume of solution may have provided a Grashof number which yielded a suitable
flow regime for growth. It is possible to engineer growth systems to give the proper
Grashof number if the parameters of the system are known. However, the need to quantify
the parameters can be by-passed by using gravity as a variable. To date this parameter has
been explored only at the limits available: 1-g and [Lg. Experiments in an induced artificial
gravity between the extremes are needed to study the effect of gravity and flow on the
growth and morphology of protein crystals.
While the lack of fluid flow in a jig environment is a factor in the improved quality
of space grown ICL crystals. The results of this study indicate that lack of fluid flow
around the crystal may not be as important factor as the lack of mixing in the drop itself.
This lack of mixing in the drop allows the protein to precipitate at the liquid-vapor interface
thereby lowering the supersaturation at which the crystal grows. This lowered
supersaturation leads to a slower growth rate which improves the crystal morphology.
More study is needed both in 1-g and \ig to determine if this mechanism is operative in
other protein systems.
III. CONTROL OF NUCLEATION
It is well known that crystal growth involves two separate processes; 1) nucleation
of the species desired, and 2) the growth of these nuclei into macroscopic crystals of
suitable size and quality for the intended application. Nucleation involves a phase
transformation in which a solid surface of the phase desired is created within a nutrient
phase. The crystal growth process, on the other hand, involves heat and mass transport,
i.e. removing the latent heat evolved during the crystallization process and supplying
nutrient to the growing crystal at an appropriate rate. It is not surprising, therefore, that the
energetics involved in these two processes are not the same. In many cases, they are
significantly different
It is of practical importance to be able to isolate and control the nucleation process
separately from the subsequent growth phase. In small molecule crystal growth, this is
most often accompli shed by introducing an appropriate seed crystal (usually of the material
being grown) into a melt, vapor, or solution. The use of a seed by-passes the nucleation
stage by providing the solid-liquid interface necessary for the crystal growth process to
proceed. In the growth of crystals containing biological macromolecules, obtaining seeds
of the appropriate size and quality is often very difficult and has rarely been an attractive
strategy. In most macromolecular crystal growth processes currently in use, the nucleation
step is achieved in the growth solution under poorly understood conditions and the growth
proceeds in a more or less uncontrolled manner.
In crystal growth from aqueous solutions, (the principal, if not only method, for
growing crystals of biological species) the driving force of nucleation is the
supersaturation. The supersaturation, c/s, where c is the actual solution concentration and s
is the concentration at the saturation point, provides the excess energy needed to form the
solid surface in the solution phase (homogeneous nucleation). The temperature-
composition diagram in Fig. 9. illustrates the relationship between solubility and
supersaturation. The solid line is the solubility curve, which divides the diagram into two
regions: unsaturated and supersaturated. A second curve, the supersolubility curve,
divides supersaturated region into labile and metastable regions. The labile region is
unstable and nuclei form readily by spontaneous fluctuations in composition. Solutions are
quite stable in the metastable state and it is only in this region where controlled crystal
growth is possible.t1! The width of the metastable region depends on a number of
factors, including purity of the starting materials. The supersaturation needed for
homogeneous nucleation is often significantly greater than that needed for growth and that
is why, after the initial nuclei are formed, growth normally proceeds in a rapid uncontrolled
manner. The supersaturation necessary for nucleation can often be reduced if a foreign
substance is present upon which the species of interest prefers to nucleate (heterogeneous
nucleation).
Starting from an undersaturated condition, the metastable region can be reached in
principle by either changing temperature at constant composition or composition at constant
temperature. Most biological macromolecular crystals are grown by the latter technique
because the temperature dependent coefficient of solubility (phase equilibria) is usually not
known and, in some cases, is negligible.
With respect to both nucleation and growth processes, temperature change methods
are usually easier to control with more precision than other techniques such as evaporation
and therefore, if possible, would be the method of choice.
One method for controlling nucleation without using seeds involves the localized
control of supersaturation in a specific region of a near-saturated bulk solution. By doing
so, nucleation will be confined to a small volume of the solution and the number of
crystallites which form will thus be severely limited. With the bulk of the solution near or
just at saturation, the crystals nucleated can then be grown in a controlled manner by
changing the solution temperature and hence the bulk supersaturation.
Localized nucleation can be accomplished by controlling temperature or solute
concentration in that region. The Thermonucleator was designed to accomplish this and
controls the localized supersaturation by controlling the temperature in an approximately
0.4 mm3 region of a >1 cm3 protein solution. The steep temperature gradients developed
can therefore restrict nucleation to a very small volume of the overall solution. An
illustration of the process is given in Fig. 10.
The Thermonucleator controls both the cold spot temperature (Ts) and the ambient
temperature around the growth cell (Te). The procedure for nucleating a desired crystal is
generally as follows: 1) The bulk solution is set at a near saturation (Fig. lOa). Under
these stable conditions, critical size nuclei should not form. 2) Ts is adjusted so that the
supersaturation is large enough to cause nucleation on the exposed surface of the cold
finger (Fig. 1 Ob). The amount of undercooling should be such that the surface of the
copper is at a temperature just inside the labile region described in Fig. 9. If the phase
equilibria data (solubility)'is not known, it is a rather simple matter to empirically find the
appropriate temperature to cause nucleation to take place on the cold finger. 3) After solid
_ -.
forms on the tip, Ts (and sometimes Te) is raised to try and dissolve all but a few of the
crystallites which may form initially. In practice, this is difficult to achieve because it is
hard to see very small crystallites in the growth cell. Laser light scattering techniques,
when developed and incorporated into the system, should provide more control of this
process. 4) After dissolving back the initial crystallites, Ts is decreased to that of the bulk
solution, and 5) The temperature of both the bulk solution and the tip are slowly lowered to
cause growth to take place on the existing seed or seeds (Fig. lOc). This proceedure has
been used to successfully grow crystals of ice, Rochelle salt and lysozyme.
Figure 11 illustrates a problem that was encountered with the nucleation of
lysozyme. Though the initial stages of crystallization seemed to show only a few nuclei,
the growth rapidly became polycrystalline. In a subsequent crystallization a different
approach was employed. The bulk temperature (Te) was set at 22°C and the cold finger
temperature (Ts) at 12°C. After 6.5 hrs, crystals appeared on the cold finger (Fig. 12) and
Te and Ts were adjusted to 20°C. Observation after an additional growth period of 15.5
hrs showed that there was a polycrystalline mass on the cold finger. The temperatures
were raised (Ts to 28°C and Te to 26°C) to dissolve all but a few of the crystals. When
only a few crystals remained (after 7.5 hrs), the temperatures were lowered to continue the
growth (Te=21°C, TS=20°C). The temperatures were lowered 2°C increments over the next
few days as growth continued. The final temperatures were Te =18°C and Ts =16°C.
During this growth sequence (Fig. 12), one large (270fi) crystal and several smaller
crystals were formed on the cold finger.
The ideal in the nucleation process is to halt the nucleation process when the first
nucleus is formed and to begin the growth phase of the crystal growth process. Careful
visual observation can reveal the presence of nuclei in the 10|im range and was used to
grow the crystal shown in Fig. 13. Using the visual approach requires some knowledge of
the time required for nucleation. Since this information is not always available and visual
inspection is not possible under (ig conditions, techniques are under study to detect
nucleation using light scattering.
Not all proteins exhibit normal solubility (increase of solubility with increasing
temperature), some, including lysozyme above 30°C, horse serum albumin and a
Chymotrypsinogen A, are less soluble as the temperature increases (retrograde solubility).
Lysozyme crystals were nucleated above 30°C (Fig. 14) to demonstrate the
Thermonucleator's ability to nucleate proteins with retrograde solubility. This was also a
demonstration of the use of the Thermonucleator to nucleate crystals without a prior
knowledge of the solubility curve, since the solubility curve of lysozyme above 30°C is not
known. Convection was noted above the nucleating tip, but there is a region of no flow
immediately adjacent to the surface of the tip which allowed nucleation to occur. This
thermally driven convection would not occur in |ig.
The current version of the thermonucleator was built as a demonstration prototype
both to test the feasibility of the concept and to provide a test bed for various monitoring
schemes. The size of the apparatus (15in x 13in x 19in), and its use of liquid nitrogen and
water baths for temperature control mitigate against its use in |ig in its present form. The
proposed design for a more space ready prototype is shown in Fig. 15. This unit will use
thermoelectric heating and cooling. The diagrams show water cooling being used to heat
sink the thermoelectric elements. This is a matter of convenience and can be replaced by air
cooled heat sinks. The growth cell is identical to that used in the current thermonucleator.
The cell is surrounded by a 0.25in temperature controlled annulus formed by 4 flat optical
windows to allow observation. The temperatures are sensed by thermistors in the annulus
and in contact with the cold spot (not shown in fig. 15). The temperatures are electronically
controlled. This new version of the thermonucleator is presently under construction.
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Fig. 15. Schematic of new thermonucleator prototype. Approximately full size.
Fig. 13. A few small lysozyme crystals on the thermonucleator cold spot. Nucleation
was stopped as soon as nuclei were vivible. Largest crystal is 40|nm.
Fig. 14. Lysozyme crystals nucleated in the retrograde solubilityy regime.
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Fig. 10. Controlled nucleation using temperature control method (thermonucleation).
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Fig. 7. ICL crystal grown from 30|J.l drop (lOmg/ml) in |ig.
50 100
Time (hrs)
150
Fig. 8. Volume ratio vs. time comparing 4(j.l drop with a 30|il drop. Simulates ICL
growth.
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Fig. 5. Volume ratio vs. time comparing 20fil drop with 20pl in a 1.88mm capillary.
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Fig. 6. Supersaturation vs. time for lysozyme comparing 20|il drop with 20(il in
1.88mm capillary. 10 crystals are nucleated at c/s = 4 and allowed to grow.
Fig. 4. ICL crystals grown in 1.88mm capillary (12mg/ml) showing a) flat termination
by a (001) type face, and
b) a wedged shaped termination by (101) type face.
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Fig. 1. Isocitrate lyase crystal (ICL) grown from 30|il hanging drop (ICL concentration
lOmg/ml).
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Fig. 2. Time lapse of ICL crystal grown from 4|il hanging drop (ICL concentration
12mg/ml).
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